Largest Pharma Companies
Companies that made the highest total payments to healthcare providers.
- 1 Novartis Pharmaceuticals Corporation $676.0M
- 2 PFIZER INC. $673.7M
- 3 ModernaTX, Inc. $665.3M
- 4 Eli Lilly and Company $652.4M
- 5 ABBVIE INC. $607.8M
CMS Open Payments · Program Year 2024
Six source-bounded views of reported General Payments to U.S. health care providers. A payment is a disclosed financial relationship, not evidence of wrongdoing.
The payment picture
Novartis Pharmaceuticals Corporation leads the company table at $676.0M, while California has the largest state total at $342.4M.
The leaderboards describe reported payments. They do not measure prescribing, clinical quality, or misconduct.
Browse by question
Company and state totals show volume. Per-physician figures adjust for the number of physician recipients. Recipient lists show disclosed totals, not a judgment about the people named.
Companies that made the highest total payments to healthcare providers.
States where pharmaceutical companies spent the most on healthcare providers.
States with the highest average pharma payment per physician.
Individual physicians who received the largest total payments from pharma companies.
Teaching hospitals that received the largest total payments from pharma companies.
Companies with the highest number of individual payment transactions.
CMS requires applicable manufacturers and group purchasing organizations to report transfers of value. PlainPharmaWatch groups the current annual release by reporting company, recipient state, recipient, and payment category so each table can be checked against its detail pages.
Totals do not show whether a payment affected patient care or prescribing. High recipient totals can reflect research, royalties, clinical-trial work, speaking, travel, or other reported activity. Read the CMS context and the methodology before drawing conclusions about a person or organization.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.